Ryo Shirai
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cystic Fibrosis Research Advances
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 16
- Medical Imaging and Pathology Studies 7
- Respiratory and Cough-Related Research 7
- Inhalation and Respiratory Drug Delivery 5
- Physiology 18
- Asthma and respiratory diseases 9
- Sarcoidosis and Beryllium Toxicity Research 5
- Co-authors
- Jun‐ichi Kadota (34 shared papers)K Kawakami (14 shared papers)S Kohno (9 shared papers)Kei Iida (9 shared papers)Koh Abe (6 shared papers)Hiroshi Ishii (21 shared papers)Takeshi Fujii (9 shared papers)Osamu Sakito (2 shared papers)
- Journals
- Clinical & Experimental Immunology (5 papers)Apmis (2 papers)Respirology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Thorax (2 papers)
- Partner nations
- JapanUnited KingdomDenmark
In The Last Decade
Ryo Shirai
58 papers receiving 996 citations
Peers
Comparison fields: 5 of 116
- Pulmonary and Respiratory Medicine 425
- Molecular Medicine 56
- Critical Care and Intensive Care Medicine 54
- Epidemiology 300
- Physiology 221
Countries citing papers authored by Ryo Shirai
This map shows the geographic impact of Ryo Shirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Shirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Shirai more than expected).
Fields of papers citing papers by Ryo Shirai
This network shows the impact of papers produced by Ryo Shirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Shirai. The network helps show where Ryo Shirai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryo Shirai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 155 | |
| 2 | 1995 | 112 | |
| 3 | 2007 | 79 | |
| 4 | 2012 | 58 | |
| 5 | 2013 | 53 | |
| 6 | 2011 | 46 | |
| 7 | 1999 | 43 | |
| 8 | 1997 | 43 | |
| 9 | 1996 | 42 | |
| 10 | 2004 | 35 | |
| 11 | 1996 | 33 | |
| 12 | 1997 | 25 | |
| 13 | 1997 | 24 | |
| 14 | 2006 | 22 | |
| 15 | 2016 | 22 | |
| 16 | 2012 | 19 | |
| 17 | 2007 | 16 | |
| 18 | 1994 | 14 | |
| 19 | 2017 | 14 | |
| 20 | 2008 | 13 |
About Ryo Shirai
Ryo Shirai is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Epidemiology, Immunology and Surgery, having authored 64 papers that have together received 1.0k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Asthma and respiratory diseases (9 papers), Medical Imaging and Pathology Studies (7 papers), Respiratory and Cough-Related Research (7 papers), Pneumonia and Respiratory Infections (5 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (425 citations), Molecular Medicine (56 citations), Critical Care and Intensive Care Medicine (54 citations), Epidemiology (300 citations) and Physiology (221 citations). Ryo Shirai has collaborated with scholars based in Japan, United Kingdom and Denmark. Frequent co-authors include Jun‐ichi Kadota, K Kawakami, S Kohno, Kei Iida, Koh Abe, Hiroshi Ishii, Takeshi Fujii, Osamu Sakito, Shigeru Kohno and Kohei HARA. Their work appears in journals such as Clinical & Experimental Immunology, Apmis, Respirology, Antimicrobial Agents and Chemotherapy and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.